智通财经APP讯,中国卫生集团(00673)发布公告,于2026年2月13日,根据该计划的条款,董事会透过向承授人发出书面通知宣布该等购股权据此注销,以行使酌情权悉数注销于2026年2月2日授出且任何承授人未有效行使的4063.8万份购股权。
由于已注销的购股权将被视为已动用,以计算该计划项下的计划授权上限及服务提供者分项限额,故计划授权上限及服务提供者分项限额项下可供未来授出的股份数目分别维持约726.15万股及478.99万股。
智通财经APP讯,中国卫生集团(00673)发布公告,于2026年2月13日,根据该计划的条款,董事会透过向承授人发出书面通知宣布该等购股权据此注销,以行使酌情权悉数注销于2026年2月2日授出且任何承授人未有效行使的4063.8万份购股权。
由于已注销的购股权将被视为已动用,以计算该计划项下的计划授权上限及服务提供者分项限额,故计划授权上限及服务提供者分项限额项下可供未来授出的股份数目分别维持约726.15万股及478.99万股。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.